IGM Biosciences Inc (IGMS)
8.89
-0.88
(-8.96%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.14
(-1.57%)
After-Hours: 20:00
IGM Biosciences Total Assets (Quarterly): 304.51M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 304.51M |
| June 30, 2024 | 336.50M |
| March 31, 2024 | 376.13M |
| December 31, 2023 | 423.41M |
| September 30, 2023 | 474.35M |
| June 30, 2023 | 480.66M |
| March 31, 2023 | 462.74M |
| December 31, 2022 | 513.50M |
| September 30, 2022 | 540.94M |
| June 30, 2022 | 582.20M |
| March 31, 2022 | 257.74M |
| December 31, 2021 | 298.13M |
| Date | Value |
|---|---|
| September 30, 2021 | 332.23M |
| June 30, 2021 | 350.66M |
| March 31, 2021 | 380.47M |
| December 31, 2020 | 408.63M |
| September 30, 2020 | 211.72M |
| June 30, 2020 | 229.06M |
| March 31, 2020 | 243.15M |
| December 31, 2019 | 261.35M |
| September 30, 2019 | 269.86M |
| June 30, 2019 | 88.43M |
| December 31, 2018 | 3.979M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
211.72M
Minimum
Sep 2020
582.20M
Maximum
Jun 2022
373.40M
Average
363.40M
Median
Total Assets (Quarterly) Benchmarks
| Moderna Inc | 15.80B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 225.56M |
| Shareholders Equity (Quarterly) | 78.95M |
| Current Ratio | 5.223 |